Sort   by:  
 Page size 
UnknownDiscordance between oncotype DX recurrence score and RSPC for predicting residual risk of recurrence in ER-positive breast cancer.
Not available
S-EPMC5847032 | biostudies-literature
UnknownSegmental Additive Tissue Engineering.
Not available
S-EPMC6052158 | biostudies-literature
UnknownExpanding colorectal cancer screening among minority women.
Not available
S-EPMC3782747 | biostudies-literature
UnknownMolecular changes in premenopausal oestrogen receptor-positive primary breast cancer in Vietnamese women after oophorectomy.
Not available
S-EPMC5703856 | biostudies-literature
UnknownShort-duration preoperative endocrine therapy alters molecular profiles to predict favourable outcome in ER+/HER2+ early breast cancer: a POETIC translational study.
Not available
S-EPMC12368290 | biostudies-literature
UnknownDevelopment and validation for research assessment of Oncotype DX® Breast Recurrence Score, EndoPredict® and Prosigna®.
Not available
S-EPMC7881187 | biostudies-literature
UnknownImpact of the menstrual cycle on commercial prognostic gene signatures in oestrogen receptor-positive primary breast cancer.
Not available
S-EPMC8558287 | biostudies-literature
UnknownCombination of mTORC1/2 inhibitor vistusertib plus fulvestrant in vitro and in vivo targets oestrogen receptor-positive endocrine-resistant breast cancer.
Not available
S-EPMC6894349 | biostudies-literature
UnknownThe Spatiotemporal Evolution of Lymph Node Spread in Early Breast Cancer.
Not available
S-EPMC6296441 | biostudies-literature
UnknownClinico-pathologic relationships with Ki67 and its change with short-term aromatase inhibitor treatment in primary ER + breast cancer: further results from the POETIC trial (CRUK/07/015).
Not available
S-EPMC10099675 | biostudies-literature
Sort   by:  
 Page size